AI-enabled multi-omic insights

FYR Bio is a precision medicine company whose EV-Omics (EVO) platform uses AI-enabled multi-omic insights to profile extracellular vesicles (EVs) in blood, decoding RNA and protein signals to support biomarkers, clinical trials, diagnostics, and drug development. Its proprietary SPARCs technology enriches disease-associated EVs to improve signal-to-noise. The company partners on study design, custom data outputs, and clinical validation across diagnostics, drug development, and precision medicine.

Read more

biomarker discoveryCLIA laboratory testingclinical validationextracellular vesicle profilingliquid biopsyRNA and protein analysis